01/31/2025
4:00 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | BALTIMORE DAVID (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
4:00 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
3:14 PM | Regulus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/15/2025
4:00 PM | Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
Get the Latest News and Ratings for RGLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
3:32 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
1:35 PM | DAFNA Capital Management LLC (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
3:26 PM | Regulus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
3:02 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G | |
08/08/2024
3:24 PM | Regulus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
3:18 PM | Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:23 AM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
3:20 PM | Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:21 PM | CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:21 PM | Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:16 PM | Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:33 PM | Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:54 PM | Regulus Therapeutics (Filer)
| Form 424B5 | |
04/21/2024
11:15 PM | Regulus Therapeutics (Filer)
| Form EFFECT | |
04/19/2024
3:13 PM | Regulus Therapeutics (Filer)
| Form ARS | |
04/10/2024
9:06 AM | FMR LLC (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G/A | |
04/09/2024
3:55 PM | Regulus Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/25/2024
3:18 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G | |
03/22/2024
3:03 PM | Deep Track Capital, LP (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13G | |
03/21/2024
3:28 PM | Regulus Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
3:18 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:30 PM | Regulus Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
03/18/2024
8:13 PM | Growth Equity Opportunities V, LLC (Filed by)
Regulus Therapeutics (Subject)
| Form SC 13D/A | |
03/15/2024
3:19 PM | PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:57 PM | Regulus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
